v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income (loss) $ (141,079) $ (47,142)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 20,227 8,538
Amortization of debt issuance costs and discount 1,436 584
Equity-based compensation expense 47,591 8,046
(Gain) loss on sale of joint ventures 0 (1,303)
(Gain) loss on change in fair value of warrants (11,506) 8,111
Deferred provision (benefit) for income taxes (25,965) (47)
Non-cash lease (benefit) expense 62 23
Purchase accounting fair value adjustment related to inventory 13,645 0
Other (2,146) (74)
Changes in assets and liabilities:    
(Increase) decrease in accounts receivable 1,595 14,496
(Increase) decrease in contract assets (5,562) (8,754)
(Increase) decrease in inventory (3,937) (537)
(Increase) decrease in prepaid expenses and other assets (3,617) (4,247)
Increase (decrease) in accounts payable and accrued expenses (9,772) (4,964)
Increase (decrease) in deferred revenue (34,094) (7,448)
Increase (decrease) in operating lease liabilities (141) (256)
Increase (decrease) in other liabilities 194 10,551
Increase (decrease) in notes payable to sellers 0 11
Net cash provided by (used in) operating activities (153,069) (24,412)
Cash flows from investing activities:    
Acquisition of businesses, net of cash acquired (151,791) (796)
Net proceeds from sale of joint ventures 0 4,598
Purchases of property, plant and equipment (11,288) (4,064)
Purchase of intangible assets (6,139) (2,788)
Net cash provided by (used in) investing activities (169,218) (3,050)
Cash flows from financing activities:    
Proceeds received from debt 191,238 42,971
Repayments of debt (127,196) (8,183)
Payment of debt issuance fees (105) (780)
Repayment of finance leases (379) (357)
Repayments of third-party advances (7,820) 7,820
Proceeds from issuance of common stock 337,806 546
Shares repurchased for settlement of employee tax withholdings on share-based awards (2,763) (1,737)
Repurchase of convertible preferred stock (63,862) 0
Net cash provided by (used in) financing activities 326,919 40,280
Effect of foreign currency rate changes on cash, cash equivalents and restricted cash 625 (2)
Net increase (decrease) in cash, cash equivalents and restricted cash 5,257 12,816
Cash, cash equivalents and restricted cash at beginning of period 49,071 30,278
Cash, cash equivalents and restricted cash at end of period $ 54,328 $ 43,094

Source